Literature DB >> 29024694

Cathepsin D non-proteolytically induces proliferation and migration in human omental microvascular endothelial cells via activation of the ERK1/2 and PI3K/AKT pathways.

Md Zahidul I Pranjol1, Nicholas J Gutowski2, Michael Hannemann3, Jacqueline L Whatmore4.   

Abstract

Epithelial ovarian cancer (EOC) frequently metastasises to the omentum, a process that requires pro-angiogenic activation of human omental microvascular endothelial cells (HOMECs) by tumour-secreted factors. We have previously shown that ovarian cancer cells secrete a range of factors that induce pro-angiogenic responses e.g. migration, in HOMECs including the lysosomal protease cathepsin D (CathD). However, the cellular mechanism by which CathD induces these cellular responses is not understood. The aim of this study was to further examine the pro-angiogenic effects of CathD in HOMECs i.e. proliferation and migration, to investigate whether these effects are dependent on CathD catalytic activity and to delineate the intracellular signalling kinases activated by CathD. We report, for the first time, that CathD significantly increases HOMEC proliferation and migration via a non-proteolytic mechanism resulting in activation of ERK1/2 and AKT. These data suggest that EOC cancer secreted CathD acts as an extracellular ligand and may play an important pro-angiogenic, and thus pro-metastatic, role by activating the omental microvasculature during EOC metastasis to the omentum.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Cathepsin D; Migration; Non-proteolytic; Proliferation

Mesh:

Substances:

Year:  2017        PMID: 29024694     DOI: 10.1016/j.bbamcr.2017.10.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Res        ISSN: 0167-4889            Impact factor:   4.739


  18 in total

1.  Protein signatures from blood plasma and urine suggest changes in vascular function and IL-12 signaling in elderly with a history of chronic diseases compared with an age-matched healthy cohort.

Authors:  Yanbao Yu; Harinder Singh; Keehwan Kwon; Tamara Tsitrin; Joann Petrini; Karen E Nelson; Rembert Pieper
Journal:  Geroscience       Date:  2020-09-24       Impact factor: 7.713

2.  'Patchiness' and basic cancer research: unravelling the proteases.

Authors:  Surinder M Soond; Maria V Kozhevnikova; Andrey A Zamyatnin
Journal:  Cell Cycle       Date:  2019-06-24       Impact factor: 4.534

3.  Autophagy triggers CTSD (cathepsin D) maturation and localization inside cells to promote apoptosis.

Authors:  Yu-Qin Di; Xiao-Lin Han; Xin-Le Kang; Di Wang; Cai-Hua Chen; Jin-Xing Wang; Xiao-Fan Zhao
Journal:  Autophagy       Date:  2020-04-23       Impact factor: 16.016

4.  Co-Expression of Androgen Receptor and Cathepsin D Defines a Triple-Negative Breast Cancer Subgroup with Poorer Overall Survival.

Authors:  Hanane Mansouri; Lindsay B Alcaraz; Caroline Mollevi; Aude Mallavialle; William Jacot; Florence Boissière-Michot; Joelle Simony-Lafontaine; Valérie Laurent-Matha; Pascal Roger; Emmanuelle Liaudet-Coopman; Séverine Guiu
Journal:  Cancers (Basel)       Date:  2020-05-15       Impact factor: 6.639

5.  New Insights into the Occurrence of Matrix Metalloproteases -2 and -9 in a Cohort of Breast Cancer Patients and Proteomic Correlations.

Authors:  Gianluca Di Cara; Maria Rita Marabeti; Rosa Musso; Ignazio Riili; Patrizia Cancemi; Ida Pucci Minafra
Journal:  Cells       Date:  2018-07-28       Impact factor: 6.600

6.  Graphene Oxide-Based Targeting of Extracellular Cathepsin D and Cathepsin L As A Novel Anti-Metastatic Enzyme Cancer Therapy.

Authors:  Tanveer A Tabish; Md Zahidul I Pranjol; David W Horsell; Alma A M Rahat; Jacqueline L Whatmore; Paul G Winyard; Shaowei Zhang
Journal:  Cancers (Basel)       Date:  2019-03-06       Impact factor: 6.639

7.  Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies.

Authors:  Yahya Ashraf; Hanane Mansouri; Valérie Laurent-Matha; Lindsay B Alcaraz; Pascal Roger; Séverine Guiu; Danielle Derocq; Gautier Robin; Henri-Alexandre Michaud; Helène Delpech; Marta Jarlier; Martine Pugnière; Bruno Robert; Anthony Puel; Lucie Martin; Flavie Landomiel; Thomas Bourquard; Oussama Achour; Ingrid Fruitier-Arnaudin; Alexandre Pichard; Emmanuel Deshayes; Andrei Turtoi; Anne Poupon; Joëlle Simony-Lafontaine; Florence Boissière-Michot; Nelly Pirot; Florence Bernex; William Jacot; Stanislas du Manoir; Charles Theillet; Jean-Pierre Pouget; Isabelle Navarro-Teulon; Nathalie Bonnefoy; André Pèlegrin; Thierry Chardès; Pierre Martineau; Emmanuelle Liaudet-Coopman
Journal:  J Immunother Cancer       Date:  2019-02-04       Impact factor: 13.751

8.  Cathepsin L-induced galectin-1 may act as a proangiogenic factor in the metastasis of high-grade serous carcinoma.

Authors:  Md Zahidul I Pranjol; Dmitry A Zinovkin; Annelie R T Maskell; Laura J Stephens; Sergey L Achinovich; Dmitry M Los'; Eldar A Nadyrov; Michael Hannemann; Nicholas J Gutowski; Jacqueline L Whatmore
Journal:  J Transl Med       Date:  2019-07-03       Impact factor: 5.531

9.  Prognostic role of high cathepsin D expression in breast cancer: a systematic review and meta-analysis.

Authors:  Junho Kang; Yeuni Yu; Seongdo Jeong; Hansong Lee; Hye Jin Heo; Jeong Jun Park; Hee Sam Na; Dai Sik Ko; Yun Hak Kim
Journal:  Ther Adv Med Oncol       Date:  2020-06-08       Impact factor: 8.168

10.  Antiproliferative and Antimetastatic Effects of Praeruptorin C on Human Non-Small Cell Lung Cancer Through Inactivating ERK/CTSD Signalling Pathways.

Authors:  Chien-Ming Liu; Huan-Ting Shen; Yi-An Lin; Yung-Luen Yu; Yong-Syuan Chen; Chung-Jung Liu; Yi-Hsien Hsieh
Journal:  Molecules       Date:  2020-04-01       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.